Multi-Center PAMPA Study

NCT05004727 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Guselkumab
DRUG: Placebo

Sponsor

NYU Langone Health

Collaborators

[object Object]